Bioinformatics analyses in bladder cancer patients found high expression of TFAP2C gene to be associated with an enhancement of adverse processes related to cancer progression, probably due to its oncogenic nature. The gene discussed is TFAP2C; the disease is urinary bladder carcinoma.